- The letter of intent is binding upon the SEA distributor, but Waldencast’s obligations are subject to the satisfaction of certain conditions.
- Assuming the satisfactory completion of its due diligence and negotiation of definitive agreements, Waldencast expects to close the transaction in the coming weeks.
- This transaction will further accelerate Waldencast’s growth in a key strategic region for the Company. The skincare market in Southeast Asia is approximately $11 billion and growing rapidly.
- The Obagi brand has achieved critical mass in this market, with widespread support from the dermatological community, and is poised for even faster growth with the benefit of Waldencast’s majority ownership and investment resources.
Chegg’s Organic Growth Remains Challenged, Says Morgan Stanley Analyst
Morgan Stanley analyst Josh Baer reiterated an Equal-Weight rating on the shares of Chegg Inc (NYSE:CHGG) and raised the price target from…